The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Lancets are a pricking needle used to obtain drops of blood for testing. Lancets are being increasingly used by patients affected by cardiovascular and endocrine-related complications. Lancets are designed to only be used once, and then disposed of in a safe way.
These devices are being used for cholesterol and glucose tests, heelstick screening tests or phenylketonuria (PKU) tests in newborns, as well as for severely burned or scarred emergency patients, extremely obese patients and thrombotic-tendency patients.
The global Lancets market was valued at US$ 1456.2 million in 2023 and is anticipated to reach US$ 2001.4 million by 2030, witnessing a CAGR of 4.6% during the forecast period 2024-2030.
The major players in global Lancets market include Roche, Lifescan, BD, etc. The top 3 players occupy about 30% shares of the global market. Europe and North America are main markets, they occupy about 70% of the global market. Ordinary lancets is the main type, with a share about 75%. Glucose tests is the main application, which holds a share about 70%.
This report aims to provide a comprehensive presentation of the global market for Lancets, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Lancets.
Report Scope
The Lancets market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Lancets market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Lancets manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
- Roche
- Lifescan
- BD
- Ascensia
- Abbott
- B. Braun
- ARKRAY
- Terumo
- I-SENS
- Nipro
- Omron
- AgaMatrix
- Smiths Medical
- Sarstedt
- Sinocare
- Yicheng
- Yuwell
- Greiner Bio One
Segment by Type
- Safety Lancets
- Ordinary Lancets
Segment by Application
- Cholesterol Tests
- Glucose Tests
- Others
Consumption by Region
- North America (United States, Canada)
- Europe (Germany, France, U.K., Italy, Netherlands)
- Asia-Pacific (China, Japan, South Korea, China Taiwan, Southeast Asia, India)
- Latin America, Middle East & Africa (Latin America, Mexico, Brazil, Turkey)
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Lancets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Lancets in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index
1 Lancets Market Overview
1.1 Product Overview and Scope of Lancets
1.2 Lancets Segment by Type
1.2.1 Global Lancets Market Value Comparison by Type (2024-2030)
1.2.2 Safety Lancets
1.2.3 Ordinary Lancets
1.3 Lancets Segment by Application
1.3.1 Global Lancets Market Value by Application: (2024-2030)
1.3.2 Cholesterol Tests
1.3.3 Glucose Tests
1.3.4 Others
1.4 Global Lancets Market Size Estimates and Forecasts
1.4.1 Global Lancets Revenue 2019-2030
1.4.2 Global Lancets Sales 2019-2030
1.4.3 Global Lancets Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Lancets Market Competition by Manufacturers
2.1 Global Lancets Sales Market Share by Manufacturers (2019-2024)
2.2 Global Lancets Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Lancets Average Price by Manufacturers (2019-2024)
2.4 Global Lancets Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Lancets, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Lancets, Product Type & Application
2.7 Lancets Market Competitive Situation and Trends
2.7.1 Lancets Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Lancets Players Market Share by Revenue
2.7.3 Global Lancets Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Lancets Retrospective Market Scenario by Region
3.1 Global Lancets Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Lancets Global Lancets Sales by Region: 2019-2030
3.2.1 Global Lancets Sales by Region: 2019-2024
3.2.2 Global Lancets Sales by Region: 2025-2030
3.3 Global Lancets Global Lancets Revenue by Region: 2019-2030
3.3.1 Global Lancets Revenue by Region: 2019-2024
3.3.2 Global Lancets Revenue by Region: 2025-2030
3.4 North America Lancets Market Facts & Figures by Country
3.4.1 North America Lancets Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Lancets Sales by Country (2019-2030)
3.4.3 North America Lancets Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Lancets Market Facts & Figures by Country
3.5.1 Europe Lancets Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Lancets Sales by Country (2019-2030)
3.5.3 Europe Lancets Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Lancets Market Facts & Figures by Country
3.6.1 Asia Pacific Lancets Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Lancets Sales by Country (2019-2030)
3.6.3 Asia Pacific Lancets Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Lancets Market Facts & Figures by Country
3.7.1 Latin America Lancets Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Lancets Sales by Country (2019-2030)
3.7.3 Latin America Lancets Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Lancets Market Facts & Figures by Country
3.8.1 Middle East and Africa Lancets Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Lancets Sales by Country (2019-2030)
3.8.3 Middle East and Africa Lancets Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Lancets Sales by Type (2019-2030)
4.1.1 Global Lancets Sales by Type (2019-2024)
4.1.2 Global Lancets Sales by Type (2025-2030)
4.1.3 Global Lancets Sales Market Share by Type (2019-2030)
4.2 Global Lancets Revenue by Type (2019-2030)
4.2.1 Global Lancets Revenue by Type (2019-2024)
4.2.2 Global Lancets Revenue by Type (2025-2030)
4.2.3 Global Lancets Revenue Market Share by Type (2019-2030)
4.3 Global Lancets Price by Type (2019-2030)
5 Segment by Application
5.1 Global Lancets Sales by Application (2019-2030)
5.1.1 Global Lancets Sales by Application (2019-2024)
5.1.2 Global Lancets Sales by Application (2025-2030)
5.1.3 Global Lancets Sales Market Share by Application (2019-2030)
5.2 Global Lancets Revenue by Application (2019-2030)
5.2.1 Global Lancets Revenue by Application (2019-2024)
5.2.2 Global Lancets Revenue by Application (2025-2030)
5.2.3 Global Lancets Revenue Market Share by Application (2019-2030)
5.3 Global Lancets Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Roche
6.1.1 Roche Corporation Information
6.1.2 Roche Description and Business Overview
6.1.3 Roche Lancets Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Roche Lancets Product Portfolio
6.1.5 Roche Recent Developments/Updates
6.2 Lifescan
6.2.1 Lifescan Corporation Information
6.2.2 Lifescan Description and Business Overview
6.2.3 Lifescan Lancets Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Lifescan Lancets Product Portfolio
6.2.5 Lifescan Recent Developments/Updates
6.3 BD
6.3.1 BD Corporation Information
6.3.2 BD Description and Business Overview
6.3.3 BD Lancets Sales, Revenue and Gross Margin (2019-2024)
6.3.4 BD Lancets Product Portfolio
6.3.5 BD Recent Developments/Updates
6.4 Ascensia
6.4.1 Ascensia Corporation Information
6.4.2 Ascensia Description and Business Overview
6.4.3 Ascensia Lancets Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Ascensia Lancets Product Portfolio
6.4.5 Ascensia Recent Developments/Updates
6.5 Abbott
6.5.1 Abbott Corporation Information
6.5.2 Abbott Description and Business Overview
6.5.3 Abbott Lancets Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Abbott Lancets Product Portfolio
6.5.5 Abbott Recent Developments/Updates
6.6 B. Braun
6.6.1 B. Braun Corporation Information
6.6.2 B. Braun Description and Business Overview
6.6.3 B. Braun Lancets Sales, Revenue and Gross Margin (2019-2024)
6.6.4 B. Braun Lancets Product Portfolio
6.6.5 B. Braun Recent Developments/Updates
6.7 ARKRAY
6.6.1 ARKRAY Corporation Information
6.6.2 ARKRAY Description and Business Overview
6.6.3 ARKRAY Lancets Sales, Revenue and Gross Margin (2019-2024)
6.4.4 ARKRAY Lancets Product Portfolio
6.7.5 ARKRAY Recent Developments/Updates
6.8 Terumo
6.8.1 Terumo Corporation Information
6.8.2 Terumo Description and Business Overview
6.8.3 Terumo Lancets Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Terumo Lancets Product Portfolio
6.8.5 Terumo Recent Developments/Updates
6.9 I-SENS
6.9.1 I-SENS Corporation Information
6.9.2 I-SENS Description and Business Overview
6.9.3 I-SENS Lancets Sales, Revenue and Gross Margin (2019-2024)
6.9.4 I-SENS Lancets Product Portfolio
6.9.5 I-SENS Recent Developments/Updates
6.10 Nipro
6.10.1 Nipro Corporation Information
6.10.2 Nipro Description and Business Overview
6.10.3 Nipro Lancets Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Nipro Lancets Product Portfolio
6.10.5 Nipro Recent Developments/Updates
6.11 Omron
6.11.1 Omron Corporation Information
6.11.2 Omron Lancets Description and Business Overview
6.11.3 Omron Lancets Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Omron Lancets Product Portfolio
6.11.5 Omron Recent Developments/Updates
6.12 AgaMatrix
6.12.1 AgaMatrix Corporation Information
6.12.2 AgaMatrix Lancets Description and Business Overview
6.12.3 AgaMatrix Lancets Sales, Revenue and Gross Margin (2019-2024)
6.12.4 AgaMatrix Lancets Product Portfolio
6.12.5 AgaMatrix Recent Developments/Updates
6.13 Smiths Medical
6.13.1 Smiths Medical Corporation Information
6.13.2 Smiths Medical Lancets Description and Business Overview
6.13.3 Smiths Medical Lancets Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Smiths Medical Lancets Product Portfolio
6.13.5 Smiths Medical Recent Developments/Updates
6.14 Sarstedt
6.14.1 Sarstedt Corporation Information
6.14.2 Sarstedt Lancets Description and Business Overview
6.14.3 Sarstedt Lancets Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Sarstedt Lancets Product Portfolio
6.14.5 Sarstedt Recent Developments/Updates
6.15 Sinocare
6.15.1 Sinocare Corporation Information
6.15.2 Sinocare Lancets Description and Business Overview
6.15.3 Sinocare Lancets Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Sinocare Lancets Product Portfolio
6.15.5 Sinocare Recent Developments/Updates
6.16 Yicheng
6.16.1 Yicheng Corporation Information
6.16.2 Yicheng Lancets Description and Business Overview
6.16.3 Yicheng Lancets Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Yicheng Lancets Product Portfolio
6.16.5 Yicheng Recent Developments/Updates
6.17 Yuwell
6.17.1 Yuwell Corporation Information
6.17.2 Yuwell Lancets Description and Business Overview
6.17.3 Yuwell Lancets Sales, Revenue and Gross Margin (2019-2024)
6.17.4 Yuwell Lancets Product Portfolio
6.17.5 Yuwell Recent Developments/Updates
6.18 Greiner Bio One
6.18.1 Greiner Bio One Corporation Information
6.18.2 Greiner Bio One Lancets Description and Business Overview
6.18.3 Greiner Bio One Lancets Sales, Revenue and Gross Margin (2019-2024)
6.18.4 Greiner Bio One Lancets Product Portfolio
6.18.5 Greiner Bio One Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Lancets Industry Chain Analysis
7.2 Lancets Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Lancets Production Mode & Process
7.4 Lancets Sales and Marketing
7.4.1 Lancets Sales Channels
7.4.2 Lancets Distributors
7.5 Lancets Customers
8 Lancets Market Dynamics
8.1 Lancets Industry Trends
8.2 Lancets Market Drivers
8.3 Lancets Market Challenges
8.4 Lancets Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
